MoonLake Immunotherapeutics remains a promising clinical-stage biotech, with potentially its first FDA approval in 2026.

Significant resources were deployed during the search in Wyoming for Grant Gardner, a missing hiker who has not been heard ...

Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company speeds up ...

Authorities in Wyoming say the search for Grant Gardner continue and have ramped up as the Lakeville native has not been ...

Grant Gardner, 38, from Minnesota, last made contact with his wife, Lauren Gardner, on July 29 after he began a “hike through ...

S.C. Swiderski’s fifth annual CAS Food Drive runs until Aug. 23 across Wisconsin, doubling all donations to local food ...

A Minnesota man has been missing for over one week after leaving for a three-day hike in Wyoming, according to the Big Horn ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) is a Switzerland-based clinical-stage biopharmaceutical company specializing in developing next-level medicines for immunologic diseases.

A hiker has been missing for a week in Wyoming after last texting his wife he had reached the top of a mountain, deputies ...

Grant Gardner from Minnesota has been missing in Wyoming since he texted his wife that his route was more 'taxing' than he ...

The sheriff's office said in a press release it received information on Aug. 1 regarding an overdue hiker and immediately ...